Unicycive Therapeutics, Inc. logo

UNCYUnicycive Therapeutics, Inc.

UNCY Stock Price, Valuation & Chart | Unicycive Therapeutics, Inc.

Compare

UNCY Historical price chart

UNCY Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization138.57M
PE Ratio-2.93
EPS-1.77
Trading Volume760.46K
Today's High/Low5.22/5.07
Dividend Yield0.00
52 Week High/Low8.74/3.71
Shares Outstanding26.70M
UNCY Financial Statement
UNCY Analyst ratings
UNCY Analysis & performance metrics

UNCY Company profile

Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment…

UNCY Management team

Management
Douglas Jermasek M.B.A.
Executive Vice President of Corporate Strategy
Pramod Gupta Ph.D.
Executive Vice President of Pharmaceutical & Business Operations
John W. Townsend CPACFO
Chief Financial Officer
Shalabh K. Gupta M.D., MPACEO
Founder, Chairman, Chief Executive Officer & President
Total 4 executives

UNCY Frequently asked questions

What is Unicycive Therapeutics, Inc. (UNCY) Stock Price?

Current stock price of Unicycive Therapeutics, Inc. (UNCY) stock is $5.190. The stock price is +2.77% higher in the session. The intraday range can be seen from this page. Volume of Unicycive Therapeutics, Inc. (UNCY) stock is 760.46K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Unicycive Therapeutics, Inc. (UNCY) stock price going up or down today?

The stock price of Unicycive Therapeutics, Inc. (UNCY) can change with earnings, company news, and overall market sentiment. Unicycive Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Unicycive Therapeutics, Inc. stock expensive at its current price?

Whether Unicycive Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for UNCY on this page is -2.93. EPS on this page is -1.77. Compare those figures with peers and growth expectations before deciding if the current Unicycive Therapeutics, Inc. price is justified.

How has the stock price of Unicycive Therapeutics, Inc. (UNCY) performed historically?

Historical performance for Unicycive Therapeutics, Inc. (UNCY) is shown on the price chart on this page. Review multi-period moves alongside volume to see how UNCY reacted to past earnings and market events.

Should I buy Unicycive Therapeutics, Inc. (UNCY) stock, at this price?

Buying Unicycive Therapeutics, Inc. (UNCY) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.